Credit reporting or other personal consumer reports -- Improper use of your report -- Complaint #12179248
Complaint Overview
Complaint ID: 12179248
Company: Equifax, INC.
Product: Credit reporting or other personal consumer reports
Sub-Product: Credit reporting
Issue: Improper use of your report
Sub-Issue: Reporting company used your report improperly
State: Georgia
ZIP Code: 30349
Date Received: 2025-02-22T12:00:00-05:00
Date Sent to Company: 2025-02-22T12:00:00-05:00
Company Response: Closed with non-monetary relief
Timely Response: Yes
Consumer Disputed: N/A
Submitted Via: Web
Consumer Narrative
The delinquent payment showing on my credit report ( XX/XX/year> ) ( XX/XX/year> ) ( XX/XX/year> ) was a result of my job loss due to COID-19. The CARES Act, which was signed into law on XXXX and ended XXXX XXXX. This act amended the Fair Credit Reporting Act ( FCRA ) to stop adverse credit reporting during the COID-19 crisis under these circumstances. Please update this information to PAID/AGREED for the following time period. Thank you for your understanding and prompt action.
Frequently Asked Questions
What is Complaint #12179248 about?
Complaint #12179248 was filed against Equifax, INC. regarding Credit reporting or other personal consumer reports specifically about Improper use of your report. It was received by the CFPB on 2025-02-22T12:00:00-05:00.
How did Equifax, INC. respond to this complaint?
The company responded with: "Closed with non-monetary relief". The response was timely.
What is the risk level of this complaint?
See the risk assessment section for details on this complaint's risk profile.
How do I file a similar complaint?
You can file a complaint with the CFPB at consumerfinance.gov/complaint. Select the appropriate product category (Credit reporting or other personal consumer reports) and describe your issue in detail.
Can I see other complaints against Equifax, INC.?
Yes, visit the Equifax, INC. company profile at readthecomplaint.com/company/equifax-inc to see all complaints, risk scores, and analysis.
Disclaimer
This analysis is AI-generated based on publicly available CFPB complaint data. It does not constitute financial or legal advice.